S&P 500   3,762.01 (-2.28%)
DOW   30,366.60 (-1.84%)
QQQ   323.61 (-1.52%)
AAPL   143.76 (+0.42%)
MSFT   235.25 (+1.26%)
FB   275.99 (-2.15%)
GOOGL   1,839.50 (-3.59%)
AMZN   3,277.67 (-1.46%)
TSLA   883.88 (+0.09%)
NVDA   521.10 (-3.03%)
BABA   262.73 (-1.20%)
CGC   38.29 (+7.80%)
GE   10.82 (-4.16%)
MU   76.50 (-3.79%)
AMD   90.64 (-4.30%)
NIO   57.95 (-3.91%)
T   29.17 (-1.95%)
F   10.81 (-3.40%)
ACB   11.60 (+8.72%)
BA   193.74 (-4.12%)
DIS   163.58 (-3.53%)
NFLX   535.76 (-4.66%)
GILD   65.54 (-1.74%)
S&P 500   3,762.01 (-2.28%)
DOW   30,366.60 (-1.84%)
QQQ   323.61 (-1.52%)
AAPL   143.76 (+0.42%)
MSFT   235.25 (+1.26%)
FB   275.99 (-2.15%)
GOOGL   1,839.50 (-3.59%)
AMZN   3,277.67 (-1.46%)
TSLA   883.88 (+0.09%)
NVDA   521.10 (-3.03%)
BABA   262.73 (-1.20%)
CGC   38.29 (+7.80%)
GE   10.82 (-4.16%)
MU   76.50 (-3.79%)
AMD   90.64 (-4.30%)
NIO   57.95 (-3.91%)
T   29.17 (-1.95%)
F   10.81 (-3.40%)
ACB   11.60 (+8.72%)
BA   193.74 (-4.12%)
DIS   163.58 (-3.53%)
NFLX   535.76 (-4.66%)
GILD   65.54 (-1.74%)
S&P 500   3,762.01 (-2.28%)
DOW   30,366.60 (-1.84%)
QQQ   323.61 (-1.52%)
AAPL   143.76 (+0.42%)
MSFT   235.25 (+1.26%)
FB   275.99 (-2.15%)
GOOGL   1,839.50 (-3.59%)
AMZN   3,277.67 (-1.46%)
TSLA   883.88 (+0.09%)
NVDA   521.10 (-3.03%)
BABA   262.73 (-1.20%)
CGC   38.29 (+7.80%)
GE   10.82 (-4.16%)
MU   76.50 (-3.79%)
AMD   90.64 (-4.30%)
NIO   57.95 (-3.91%)
T   29.17 (-1.95%)
F   10.81 (-3.40%)
ACB   11.60 (+8.72%)
BA   193.74 (-4.12%)
DIS   163.58 (-3.53%)
NFLX   535.76 (-4.66%)
GILD   65.54 (-1.74%)
S&P 500   3,762.01 (-2.28%)
DOW   30,366.60 (-1.84%)
QQQ   323.61 (-1.52%)
AAPL   143.76 (+0.42%)
MSFT   235.25 (+1.26%)
FB   275.99 (-2.15%)
GOOGL   1,839.50 (-3.59%)
AMZN   3,277.67 (-1.46%)
TSLA   883.88 (+0.09%)
NVDA   521.10 (-3.03%)
BABA   262.73 (-1.20%)
CGC   38.29 (+7.80%)
GE   10.82 (-4.16%)
MU   76.50 (-3.79%)
AMD   90.64 (-4.30%)
NIO   57.95 (-3.91%)
T   29.17 (-1.95%)
F   10.81 (-3.40%)
ACB   11.60 (+8.72%)
BA   193.74 (-4.12%)
DIS   163.58 (-3.53%)
NFLX   535.76 (-4.66%)
GILD   65.54 (-1.74%)
Log in
NASDAQ:SNPS

Synopsys Stock Forecast, Price & News

$259.87
-6.22 (-2.34 %)
(As of 01/27/2021 02:15 PM ET)
Add
Compare
Today's Range
$257.84
Now: $259.87
$266.26
50-Day Range
$232.77
MA: $255.82
$273.43
52-Week Range
$104.90
Now: $259.87
$280.11
Volume21,802 shs
Average Volume683,403 shs
Market Capitalization$39.77 billion
P/E Ratio61.00
Dividend YieldN/A
Beta1.1
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. The company also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating point components, and Arm AMBA interconnect fabric and peripherals. In addition, it offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, the company provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, it offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle; manufacturing solutions; and professional and other services. It has a collaboration with IBM Research's AI Hardware Center to advance the development of chip architectures and design methodologies critical to the next generation of AI chips. Synopsys, Inc. was founded in 1986 and is headquartered in Mountain View, California.
Synopsys logo

MarketRank

Overall MarketRank

1.63 out of 5 stars

Computer And Technology Sector

215th out of 1,510 stocks

Prepackaged Software Industry

41st out of 285 stocks

Analyst Opinion: 2.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryApplication Software
Current SymbolNASDAQ:SNPS
CUSIP87160710
Phone650-584-5000
Employees15,036
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.69 billion
Cash Flow$6.23 per share
Book Value$32.37 per share

Profitability

Net Income$664.35 million

Miscellaneous

Market Cap$39.77 billion
Next Earnings Date2/17/2021 (Estimated)
OptionableOptionable
$259.87
-6.22 (-2.34 %)
(As of 01/27/2021 02:15 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SNPS News and Ratings via Email

Sign-up to receive the latest news and ratings for SNPS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Synopsys (NASDAQ:SNPS) Frequently Asked Questions

How has Synopsys' stock been impacted by Coronavirus (COVID-19)?

Synopsys' stock was trading at $131.74 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SNPS shares have increased by 97.5% and is now trading at $260.13.
View which stocks have been most impacted by COVID-19
.

Is Synopsys a buy right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Synopsys in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Synopsys stock.
View analyst ratings for Synopsys
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Synopsys?

Wall Street analysts have given Synopsys a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Synopsys wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Dr. Aart J. de Geus and Dr. Chi-Foon Chan's approval rating as Synopsys' CEO?

1,170 employees have rated Synopsys CEO Dr. Aart J. de Geus and Dr. Chi-Foon Chan on Glassdoor.com. Dr. Aart J. de Geus and Dr. Chi-Foon Chan has an approval rating of 95% among Synopsys' employees. This puts Dr. Aart J. de Geus and Dr. Chi-Foon Chan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

When is Synopsys' next earnings date?

Synopsys is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for Synopsys
.

How were Synopsys' earnings last quarter?

Synopsys, Inc. (NASDAQ:SNPS) posted its quarterly earnings results on Tuesday, December, 1st. The semiconductor company reported $1.58 EPS for the quarter, topping the Zacks' consensus estimate of $1.57 by $0.01. The semiconductor company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.02 billion. Synopsys had a net margin of 18.03% and a trailing twelve-month return on equity of 14.81%. The firm's revenue for the quarter was up 20.4% on a year-over-year basis. During the same quarter last year, the business posted $1.15 earnings per share.
View Synopsys' earnings history
.

How will Synopsys' stock buyback program work?

Synopsys declared that its Board of Directors has initiated a stock buyback plan on Friday, June 19th 2020, which allows the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase up to 1.7% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's leadership believes its shares are undervalued.

What guidance has Synopsys issued on next quarter's earnings?

Synopsys updated its FY21 earnings guidance on Wednesday, December, 2nd. The company provided EPS guidance of $6.23-$6.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.16. The company issued revenue guidance of $4.0-$4.05 billion, compared to the consensus revenue estimate of $3.98 billion.

What price target have analysts set for SNPS?

14 brokerages have issued twelve-month price targets for Synopsys' stock. Their forecasts range from $160.00 to $290.00. On average, they anticipate Synopsys' share price to reach $243.69 in the next year. This suggests that the stock has a possible downside of 6.3%.
View analysts' price targets for Synopsys
or view Wall Street analyst' top-rated stocks.

Who are some of Synopsys' key competitors?

What other stocks do shareholders of Synopsys own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Synopsys investors own include NVIDIA (NVDA), PayPal (PYPL), Alibaba Group (BABA), Square (SQ), salesforce.com (CRM), Advanced Micro Devices (AMD), Adobe (ADBE), Tesla (TSLA), Netflix (NFLX) and Micron Technology (MU).

Who are Synopsys' key executives?

Synopsys' management team includes the following people:
  • Dr. Aart J. de Geus, Co-Founder, Chairman & Co-CEO (Age 67, Pay $1.84M)
  • Dr. Chi-Foon Chan, Co-CEO, Pres & Director (Age 72, Pay $1.84M)
  • Mr. Trac Pham, Chief Financial Officer (Age 52, Pay $869.65k)
  • Mr. John F. Runkel Jr., Gen. Counsel & Corp. Sec. (Age 65, Pay $685.15k)
  • Mr. Joseph W. Logan, Sales & Corp. Marketing Officer (Age 61, Pay $1.13M)
  • Mr. Sassine Ghazi, Chief Operating Officer
  • Mr. Sudhindra Kankanwadi, Sr. VP, Chief Accounting Officer & Corp. Controller (Age 50)
  • Mr. Sriram Sitaraman, Chief Information Officer
  • Ms. Lisa L. Ewbank, VP of Investor Relations
  • Ms. Janet Sue Collinson, HR & Facilities Officer (Age 60)

What is Synopsys' stock symbol?

Synopsys trades on the NASDAQ under the ticker symbol "SNPS."

Who are Synopsys' major shareholders?

Synopsys' stock is owned by many different retail and institutional investors. Top institutional investors include Congress Asset Management Co. MA (0.38%), Strs Ohio (0.21%), Ardevora Asset Management LLP (0.16%), New York State Teachers Retirement System (0.14%), AMI Asset Management Corp (0.12%) and Artemis Investment Management LLP (0.08%). Company insiders that own Synopsys stock include Bruce R Chizen, Chi-Foon Chan, Chrysostomos L Nikias, Geus Aart De, Janice Chaffin, John F Runkel Jr, John Schwarz, Joseph W Logan, Mercedes Johnson, Roy Vallee, Sassine Ghazi, Steven Walske, Sudhindra Kankanwadi and Trac Pham.
View institutional ownership trends for Synopsys
.

Which institutional investors are selling Synopsys stock?

SNPS stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC, Ardevora Asset Management LLP, Congress Asset Management Co. MA, Pacer Advisors Inc., New York State Teachers Retirement System, AMI Asset Management Corp, Columbus Circle Investors, and State of Alaska Department of Revenue. Company insiders that have sold Synopsys company stock in the last year include Bruce R Chizen, Chi-Foon Chan, Chrysostomos L Nikias, Janice Chaffin, John F Runkel Jr, Joseph W Logan, Mercedes Johnson, Sassine Ghazi, Steven Walske, Sudhindra Kankanwadi, and Trac Pham.
View insider buying and selling activity for Synopsys
or view top insider-selling stocks.

Which institutional investors are buying Synopsys stock?

SNPS stock was bought by a variety of institutional investors in the last quarter, including Sawgrass Asset Management LLC, Strs Ohio, Pendal Group Limited, Tributary Capital Management LLC, Louisiana State Employees Retirement System, Capital CS Group LLC, Candriam Luxembourg S.C.A., and Kestra Advisory Services LLC.
View insider buying and selling activity for Synopsys
or or view top insider-buying stocks.

How do I buy shares of Synopsys?

Shares of SNPS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Synopsys' stock price today?

One share of SNPS stock can currently be purchased for approximately $260.13.

How big of a company is Synopsys?

Synopsys has a market capitalization of $39.81 billion and generates $3.69 billion in revenue each year. The semiconductor company earns $664.35 million in net income (profit) each year or $4.27 on an earnings per share basis. Synopsys employs 15,036 workers across the globe.

What is Synopsys' official website?

The official website for Synopsys is www.synopsys.com.

How can I contact Synopsys?

Synopsys' mailing address is 690 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The semiconductor company can be reached via phone at 650-584-5000 or via email at [email protected]

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.